Oncology treatment specialist Geron (GERN +14.3%) zooms higher, perhaps due to a positive...

|About: Geron Corporation (GERN)|By:, SA News Editor

Oncology treatment specialist Geron (GERN +14.3%) zooms higher, perhaps due to a positive Seeking Alpha blog which recommends purchase for investors with room for some speculation in their portfolios. Geron's drugs "have the potential to change the way cancer is treated," the article says, citing six potential catalysts for GERN's stock over the next year.